Pressure Surface denied as non-formulary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for pressure surface are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denies Pressure-Relieving Surfaces as Non-Formulary

Blue Cross Blue Shield plans maintain formularies and covered-equipment lists that specify which support-surface categories and product tiers are included. A non-formulary denial means the requested surface falls outside the plan's standard equipment schedule — often because the product is a higher-tier specialty surface when a lower-tier alternative exists on the covered list.

## Why This Denial Is Appealable

Non-formulary denials are not final. Most BCBS plans allow exceptions when the formulary alternative is clinically inadequate for a specific patient. If the listed alternative has been tried and failed, is contraindicated by your physician's clinical judgment, or is otherwise inappropriate given your wound characteristics and clinical history, a formulary exception is the correct pathway. The plan must evaluate your individual circumstances, not simply enforce the tier rule.

## Federal Appeal Framework

• Internal appeal / formulary exception: Request a formulary exception simultaneously with or immediately after the denial. This is distinct from, and often faster than, a standard medical-necessity appeal.
• ACA §2719: Guarantees at least one internal appeal with a written decision and access to external review for adverse benefit determinations.
• External review: If the internal exception or appeal is denied, request independent external review. The reviewer is not bound by BCBS's formulary structure and will assess clinical appropriateness on its merits.
• Timeline: External review requests are typically due within four months of the final adverse decision. Expedited review (72-hour decision) is available for urgent clinical situations.

## Documents to Gather

• Formulary alternative trial records: Documentation that the plan's covered surface was tried, with dates, duration of use, and the specific clinical outcome (wound progression, skin breakdown, inadequate pressure redistribution).
• Prescriber justification: A letter from the ordering clinician explaining why the non-formulary surface is required and why the covered alternative is clinically insufficient for this patient's specific presentation.
• Wound assessment: Current and serial wound documentation showing clinical trajectory that supports the need for the requested product category.
• BCBS coverage and formulary documents: Obtain the specific equipment schedule and formulary exception policy from BCBS. These define the criteria you must meet for an exception to be granted.

## Criteria-Mapping Structure

Pull the formulary exception criteria from BCBS's policy — they typically include requirements such as documented failure of the formulary alternative, clinical contraindication, or unique patient need. Map each criterion in a table: left column lists the policy requirement verbatim; right column cites the chart entry, letter paragraph, or test result that satisfies it. Submitting this structured mapping alongside the prescriber letter gives reviewers everything they need to approve the exception without back-and-forth requests for additional information.